Patent ID: 7846447

Claim:
A pharmaceutical composition comprising at least two antigens and a pharmaceutically acceptable carrier, wherein each of said antigens induces or is capable of inducing a cutaneous delayed type hypersensitivity response in a mammalian subject; and the composition is capable of treating a benign epithelial tumor caused by a papilloma virus in a mammalian subject; wherein the first of the at least two antigens is selected from the group consisting of a candida antigen, a trichophyton antigen and a mumps antigen, and the second of the at least two antigens is selected from the group consisting of a candida antigen, a trichophyton antigen, and a mumps antigen wherein the second and first antigens are not the same; and the at least two antigens comprise a candida antigen and a trichophyton antigen, or a candida antigen and a mumps antigen, or a trichophyton antigen and a mumps antigen.